APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Opioid Patch

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-Opioid Patch Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchNon-Opioid Patch Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Opioid Patch Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Non-Opioid Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Opioid Patch Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Opioid Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Non-Opioid Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Opioid Patch include Teva Pharmaceutical Industries Ltd, Johnson and Johnson, Viatris Inc., Sorrento Therapeutics Inc., Purdue Pharma L.P., NEXGEL Advanced Hydrogel Solutions, Hisamitsu Pharmaceutical Co.,Inc., Grunenthal and Endo International plc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-Opioid Patch market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-Opioid Patch market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-Opioid Patch market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-Opioid Patch.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-Opioid Patch market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-Opioid Patch Market by Company

Teva Pharmaceutical Industries Ltd

Johnson and Johnson

Viatris Inc.

Sorrento Therapeutics Inc.

Purdue Pharma L.P.

NEXGEL Advanced Hydrogel Solutions

Hisamitsu Pharmaceutical Co.,Inc.

Grunenthal

Endo International plc.

Amneal Pharmaceuticals LLC

Non-Opioid Patch Segment by Type

Prescription Medicines

OTC Medicines

Non-Opioid Patch Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Non-Opioid Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Opioid Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Opioid Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Opioid Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-Opioid Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Prescription Medicines Table 2. Major Company of OTC Medicines Table 3. Global Non-Opioid Patch Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 5. Global Non-Opioid Patch Sales Market Share in Volume by Type (2021-2026) Table 6. Global Non-Opioid Patch Sales by Type (2021-2026) & (US$ Million) Table 7. Global Non-Opioid Patch Sales Market Share in Value by Type (2021-2026) Table 8. Global Non-Opioid Patch Price by Type (2021-2026) & (US$/unit) Table 9. Global Non-Opioid Patch Sales by Type (2027-2032) & (k units) Table 10. Global Non-Opioid Patch Sales Market Share in Volume by Type (2027-2032) Table 11. Global Non-Opioid Patch Sales by Type (2027-2032) & (US$ Million) Table 12. Global Non-Opioid Patch Sales Market Share in Value by Type (2027-2032) Table 13. Global Non-Opioid Patch Price by Type (2027-2032) & (US$/unit) Table 14. North America Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 15. North America Non-Opioid Patch Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 17. Europe Non-Opioid Patch Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Non-Opioid Patch Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 21. Latin America Non-Opioid Patch Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Non-Opioid Patch Sales by Type (2021-2026) & (US$ Million) Table 24. Non-Opioid Patch Industry Trends Table 25. Non-Opioid Patch Industry Drivers Table 26. Non-Opioid Patch Industry Opportunities and Challenges Table 27. Non-Opioid Patch Industry Restraints Table 28. Global Non-Opioid Patch Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Non-Opioid Patch Revenue Market Share by Company (2021-2026) Table 30. Global Non-Opioid Patch Sales by Company (2021-2026) & (k units) Table 31. Global Non-Opioid Patch Sales Share by Company (2021-2026) Table 32. Global Non-Opioid Patch Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Non-Opioid Patch Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Non-Opioid Patch Major Company Production Sites and Headquarters Table 35. Global Non-Opioid Patch Company, Product Type & Application Table 36. Global Non-Opioid Patch Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Non-Opioid Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Non-Opioid Patch Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Non-Opioid Patch Sales by Region (2021-2026) & (k units) Table 41. Global Non-Opioid Patch Sales Market Share in Volume by Region (2021-2026) Table 42. Global Non-Opioid Patch Sales by Region (2021-2026) & (US$ Million) Table 43. Global Non-Opioid Patch Sales Market Share in Value by Region (2021-2026) Table 44. Global Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Non-Opioid Patch Sales by Region (2027-2032) & (k units) Table 46. Global Non-Opioid Patch Sales Market Share in Volume by Region (2027-2032) Table 47. Global Non-Opioid Patch Sales by Region (2027-2032) & (US$ Million) Table 48. Global Non-Opioid Patch Sales Market Share in Value by Region (2027-2032) Table 49. Global Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Non-Opioid Patch Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 52. Global Non-Opioid Patch Sales Market Share in Volume by Application (2021-2026) Table 53. Global Non-Opioid Patch Sales by Application (2021-2026) & (US$ Million) Table 54. Global Non-Opioid Patch Sales Market Share in Value by Application (2021-2026) Table 55. Global Non-Opioid Patch Price by Application (2021-2026) & (US$/unit) Table 56. Global Non-Opioid Patch Sales by Application (2027-2032) & (k units) Table 57. Global Non-Opioid Patch Sales Market Share in Volume by Application (2027-2032) Table 58. Global Non-Opioid Patch Sales by Application (2027-2032) & (US$ Million) Table 59. Global Non-Opioid Patch Sales Market Share in Value by Application (2027-2032) Table 60. Global Non-Opioid Patch Price by Application (2027-2032) & (US$/unit) Table 61. North America Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 62. North America Non-Opioid Patch Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 64. Europe Non-Opioid Patch Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Non-Opioid Patch Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 68. Latin America Non-Opioid Patch Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Non-Opioid Patch Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceutical Industries Ltd Company Information Table 72. Teva Pharmaceutical Industries Ltd Business Overview Table 73. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio Table 75. Teva Pharmaceutical Industries Ltd Recent Development Table 76. Johnson and Johnson Company Information Table 77. Johnson and Johnson Business Overview Table 78. Johnson and Johnson Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Johnson and Johnson Non-Opioid Patch Product Portfolio Table 80. Johnson and Johnson Recent Development Table 81. Viatris Inc. Company Information Table 82. Viatris Inc. Business Overview Table 83. Viatris Inc. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Viatris Inc. Non-Opioid Patch Product Portfolio Table 85. Viatris Inc. Recent Development Table 86. Sorrento Therapeutics Inc. Company Information Table 87. Sorrento Therapeutics Inc. Business Overview Table 88. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio Table 90. Sorrento Therapeutics Inc. Recent Development Table 91. Purdue Pharma L.P. Company Information Table 92. Purdue Pharma L.P. Business Overview Table 93. Purdue Pharma L.P. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Purdue Pharma L.P. Non-Opioid Patch Product Portfolio Table 95. Purdue Pharma L.P. Recent Development Table 96. NEXGEL Advanced Hydrogel Solutions Company Information Table 97. NEXGEL Advanced Hydrogel Solutions Business Overview Table 98. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio Table 100. NEXGEL Advanced Hydrogel Solutions Recent Development Table 101. Hisamitsu Pharmaceutical Co.,Inc. Company Information Table 102. Hisamitsu Pharmaceutical Co.,Inc. Business Overview Table 103. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio Table 105. Hisamitsu Pharmaceutical Co.,Inc. Recent Development Table 106. Grunenthal Company Information Table 107. Grunenthal Business Overview Table 108. Grunenthal Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Grunenthal Non-Opioid Patch Product Portfolio Table 110. Grunenthal Recent Development Table 111. Endo International plc. Company Information Table 112. Endo International plc. Business Overview Table 113. Endo International plc. Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Endo International plc. Non-Opioid Patch Product Portfolio Table 115. Endo International plc. Recent Development Table 116. Amneal Pharmaceuticals LLC Company Information Table 117. Amneal Pharmaceuticals LLC Business Overview Table 118. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio Table 120. Amneal Pharmaceuticals LLC Recent Development Table 121. North America Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 123. North America Non-Opioid Patch Sales Market Share by Country (2021-2026) Table 124. North America Non-Opioid Patch Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Non-Opioid Patch Sales Market Share Forecast by Country (2027-2032) Table 126. North America Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Non-Opioid Patch Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Non-Opioid Patch Market Share by Country (2021-2026) Table 129. North America Non-Opioid Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Non-Opioid Patch Market Share Forecast by Country (2027-2032) Table 131. Europe Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 133. Europe Non-Opioid Patch Sales Market Share by Country (2021-2026) Table 134. Europe Non-Opioid Patch Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Non-Opioid Patch Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Non-Opioid Patch Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Non-Opioid Patch Market Share by Country (2021-2026) Table 139. Europe Non-Opioid Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Non-Opioid Patch Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Non-Opioid Patch Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Non-Opioid Patch Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Non-Opioid Patch Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Non-Opioid Patch Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Non-Opioid Patch Market Share by Country (2021-2026) Table 149. Asia-Pacific Non-Opioid Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Non-Opioid Patch Market Share Forecast by Country (2027-2032) Table 151. Latin America Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 153. Latin America Non-Opioid Patch Sales Market Share by Country (2021-2026) Table 154. Latin America Non-Opioid Patch Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Non-Opioid Patch Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Non-Opioid Patch Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Non-Opioid Patch Market Share by Country (2021-2026) Table 159. Latin America Non-Opioid Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Non-Opioid Patch Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Non-Opioid Patch Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Non-Opioid Patch Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Non-Opioid Patch Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Non-Opioid Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Non-Opioid Patch Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Non-Opioid Patch Market Share by Country (2021-2026) Table 169. Middle East and Africa Non-Opioid Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Non-Opioid Patch Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Non-Opioid Patch Distributors List Table 174. Non-Opioid Patch Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Non-Opioid Patch Image Figure 2. Global Non-Opioid Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Opioid Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Opioid Patch Sales (2021-2032) & (k units) Figure 5. Prescription Medicines Image Figure 6. Global Prescription Medicines Sales YoY Growth (2021-2032) & (k units) Figure 7. OTC Medicines Image Figure 8. Global OTC Medicines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Non-Opioid Patch Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Non-Opioid Patch Market Share by Type 2025 VS 2032 Figure 11. North America Non-Opioid Patch Sales Market Share in Volume by Type in 2025 Figure 12. North America Non-Opioid Patch Sales Market Share in Value by Type in 2025 Figure 13. Europe Non-Opioid Patch Sales Market Share in Volume by Type in 2025 Figure 14. Europe Non-Opioid Patch Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Non-Opioid Patch Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Non-Opioid Patch Sales Market Share in Value by Type in 2025 Figure 17. Latin America Non-Opioid Patch Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Non-Opioid Patch Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Non-Opioid Patch Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Non-Opioid Patch Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Non-Opioid Patch Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacies Image Figure 24. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 25. Drug Stores Image Figure 26. Global Drug Stores Sales YoY Growth (2021-2032) & (k units) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Non-Opioid Patch Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Non-Opioid Patch Market Share by Application 2025 VS 2032 Figure 31. North America Non-Opioid Patch Sales Market Share in Volume by Application in 2025 Figure 32. North America Non-Opioid Patch Sales Market Share in Value by Application in 2025 Figure 33. Europe Non-Opioid Patch Sales Market Share in Volume by Application in 2025 Figure 34. Europe Non-Opioid Patch Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Non-Opioid Patch Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Non-Opioid Patch Sales Market Share in Value by Application in 2025 Figure 37. Latin America Non-Opioid Patch Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Non-Opioid Patch Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Non-Opioid Patch Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Non-Opioid Patch Sales Market Share in Value by Application in 2025 Figure 41. North America Non-Opioid Patch Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Non-Opioid Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Non-Opioid Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Non-Opioid Patch Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Non-Opioid Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Non-Opioid Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Non-Opioid Patch Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Non-Opioid Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Non-Opioid Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Non-Opioid Patch Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Non-Opioid Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Non-Opioid Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Non-Opioid Patch Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Non-Opioid Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Non-Opioid Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Non-Opioid Patch Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Non-Opioid Patch Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Medicines
  • OTC Medicines
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Johnson and Johnson
  • Viatris Inc.
  • Sorrento Therapeutics Inc.
  • Purdue Pharma L.P.
  • NEXGEL Advanced Hydrogel Solutions
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Grunenthal
  • Endo International plc.
  • Amneal Pharmaceuticals LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-Opioid Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-Opioid Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-Opioid Patch Market by Type
  6. 1.3.1 Prescription Medicines
  7. 1.3.2 OTC Medicines
  8. 1.4 Global Non-Opioid Patch Market Size by Type
  9. 1.4.1 Global Non-Opioid Patch Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Non-Opioid Patch Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Non-Opioid Patch Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Non-Opioid Patch Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Non-Opioid Patch Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Non-Opioid Patch Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Non-Opioid Patch Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Non-Opioid Patch Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-Opioid Patch Industry Trends
  2. 2.2 Non-Opioid Patch Industry Drivers
  3. 2.3 Non-Opioid Patch Industry Opportunities and Challenges
  4. 2.4 Non-Opioid Patch Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-Opioid Patch Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-Opioid Patch Sales (2021-2026)
  3. 3.3 Global Top Players by Non-Opioid Patch Price (2021-2026)
  4. 3.4 Global Non-Opioid Patch Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Opioid Patch Major Company Production Sites & Headquarters
  6. 3.6 Global Non-Opioid Patch Company, Product Type & Application
  7. 3.7 Global Non-Opioid Patch Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Opioid Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Opioid Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Opioid Patch Tier 1, Tier 2, and Tier 3
4 Non-Opioid Patch Regional Status and Outlook
  1. 4.1 Global Non-Opioid Patch Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-Opioid Patch Historic Market Size by Region
  3. 4.2.1 Global Non-Opioid Patch Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-Opioid Patch Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-Opioid Patch Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-Opioid Patch Forecasted Market Size by Region
  7. 4.3.1 Global Non-Opioid Patch Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-Opioid Patch Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-Opioid Patch Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-Opioid Patch by Application
  1. 5.1 Non-Opioid Patch Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Non-Opioid Patch Market Size by Application
  6. 5.2.1 Global Non-Opioid Patch Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Non-Opioid Patch Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Non-Opioid Patch Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Non-Opioid Patch Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Non-Opioid Patch Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Non-Opioid Patch Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Non-Opioid Patch Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Non-Opioid Patch Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries Ltd
  2. 6.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 6.2 Johnson and Johnson
  8. 6.2.1 Johnson and Johnson Company Information
  9. 6.2.2 Johnson and Johnson Business Overview
  10. 6.2.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
  12. 6.2.5 Johnson and Johnson Recent Developments
  13. 6.3 Viatris Inc.
  14. 6.3.1 Viatris Inc. Company Information
  15. 6.3.2 Viatris Inc. Business Overview
  16. 6.3.3 Viatris Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Viatris Inc. Non-Opioid Patch Product Portfolio
  18. 6.3.5 Viatris Inc. Recent Developments
  19. 6.4 Sorrento Therapeutics Inc.
  20. 6.4.1 Sorrento Therapeutics Inc. Company Information
  21. 6.4.2 Sorrento Therapeutics Inc. Business Overview
  22. 6.4.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
  24. 6.4.5 Sorrento Therapeutics Inc. Recent Developments
  25. 6.5 Purdue Pharma L.P.
  26. 6.5.1 Purdue Pharma L.P. Company Information
  27. 6.5.2 Purdue Pharma L.P. Business Overview
  28. 6.5.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
  30. 6.5.5 Purdue Pharma L.P. Recent Developments
  31. 6.6 NEXGEL Advanced Hydrogel Solutions
  32. 6.6.1 NEXGEL Advanced Hydrogel Solutions Company Information
  33. 6.6.2 NEXGEL Advanced Hydrogel Solutions Business Overview
  34. 6.6.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
  36. 6.6.5 NEXGEL Advanced Hydrogel Solutions Recent Developments
  37. 6.7 Hisamitsu Pharmaceutical Co.,Inc.
  38. 6.7.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
  39. 6.7.2 Hisamitsu Pharmaceutical Co.,Inc. Business Overview
  40. 6.7.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
  42. 6.7.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments
  43. 6.8 Grunenthal
  44. 6.8.1 Grunenthal Company Information
  45. 6.8.2 Grunenthal Business Overview
  46. 6.8.3 Grunenthal Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Grunenthal Non-Opioid Patch Product Portfolio
  48. 6.8.5 Grunenthal Recent Developments
  49. 6.9 Endo International plc.
  50. 6.9.1 Endo International plc. Company Information
  51. 6.9.2 Endo International plc. Business Overview
  52. 6.9.3 Endo International plc. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Endo International plc. Non-Opioid Patch Product Portfolio
  54. 6.9.5 Endo International plc. Recent Developments
  55. 6.10 Amneal Pharmaceuticals LLC
  56. 6.10.1 Amneal Pharmaceuticals LLC Company Information
  57. 6.10.2 Amneal Pharmaceuticals LLC Business Overview
  58. 6.10.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
  60. 6.10.5 Amneal Pharmaceuticals LLC Recent Developments
7 North America by Country
  1. 7.1 North America Non-Opioid Patch Sales by Country
  2. 7.1.1 North America Non-Opioid Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-Opioid Patch Sales by Country (2021-2026)
  4. 7.1.3 North America Non-Opioid Patch Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-Opioid Patch Market Size by Country
  6. 7.2.1 North America Non-Opioid Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-Opioid Patch Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-Opioid Patch Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-Opioid Patch Sales by Country
  2. 8.1.1 Europe Non-Opioid Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-Opioid Patch Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-Opioid Patch Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-Opioid Patch Market Size by Country
  6. 8.2.1 Europe Non-Opioid Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-Opioid Patch Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-Opioid Patch Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-Opioid Patch Sales by Country
  2. 9.1.1 Asia-Pacific Non-Opioid Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-Opioid Patch Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-Opioid Patch Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-Opioid Patch Market Size by Country
  6. 9.2.1 Asia-Pacific Non-Opioid Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-Opioid Patch Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-Opioid Patch Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-Opioid Patch Sales by Country
  2. 10.1.1 South America Non-Opioid Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-Opioid Patch Sales by Country (2021-2026)
  4. 10.1.3 South America Non-Opioid Patch Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-Opioid Patch Market Size by Country
  6. 10.2.1 South America Non-Opioid Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-Opioid Patch Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-Opioid Patch Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-Opioid Patch Sales by Country
  2. 11.1.1 Middle East and Africa Non-Opioid Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-Opioid Patch Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-Opioid Patch Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-Opioid Patch Market Size by Country
  6. 11.2.1 Middle East and Africa Non-Opioid Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-Opioid Patch Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-Opioid Patch Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-Opioid Patch Value Chain Analysis
  2. 12.1.1 Non-Opioid Patch Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-Opioid Patch Production Mode & Process
  7. 12.2 Non-Opioid Patch Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-Opioid Patch Distributors
  10. 12.2.3 Non-Opioid Patch Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst